CFAR-RePORT cross-consortia studies to elucidate the role of HIV in TB immunopathogenesis and biomarker delivery
DOWNLOAD the complete RFP: https://cfar.globalhealth.harvard.edu/files/cfar/files/report_cfar_rfp.pdf
Visit the CRDF website for a full application package: http://www.crdfglobal.org/funding-opportunities/RePORT-CFAR
CRDF Global is accepting proposals on behalf of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health to fund, collaborative global HIV/TB research projects across Regional Prospective Observational Research in TB (RePORT) International consortia (India, Brazil, Indonesia, South Africa, China and the Philippines) and the 19 Centers for AIDS Research (CFAR) allowing for work to extend across the 2 programs as well as sites and countries. The results of such research efforts will significantly impact HIV/TB clinical care and disease outcomes. Funding for this research award initiative is administered by CRDF Global, utilizing funds provided by U.S. National Institutes of Health (NIH).
Eligible Research Scope: To support ongoing projects by participating members of CFAR and RePORT consortia, to implement cross-cutting research activities, and to support hypothesis-driven research on TB bio-markers with translational potential to impact TB/HIV epidemic.
Friday, November 9th, 2018 (23:59) U.S. Eastern Standard Time (EST)
Thursday, February 21st, 2019 (23:59) U.S. Eastern Standard Time (EST)